Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 759-766

  Lesage, Anne S ^a   Peeters, Luc ^a   Leysen, Josee E ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; LUBELUZOLE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; DRUG CONFORMATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; GLIOMA CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR NEUROPATHY; STEREOISOMERISM; STROKE; STRUCTURE ACTIVITY RELATION;

ANIMALS; ARGININE; CELLS, CULTURED; CYCLIC GMP; GLUTAMIC ACID; GUANYLATE CYCLASE; HIPPOCAMPUS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; PIPERIDINES; RATS; STEREOISOMERISM; THIAZOLES;

EID: 0030426710     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BECKMAN, J. S., BECKMAN, T. W., CHEN, J., MARSHALL, P. A. AND FREEMAN, B. A.: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87: 1620-1624, 1990.
2. BERGMEYER, H. U. AND BERNT, E.: UV-assay with puruvate and NADH. In Methods of Enzymatic Analysis, ed. by H. U. Bergmeyer, pp. 574-579, Academic Press, New York, 1974.
3. BRADFORD, M. M.: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
4. BREDT, D. S. AND SNYDER, S. H.: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86: 9030-9033, 1989.
5. BREDT, D. S. AND SNYDER, S. H.: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87: 682-685, 1990.
6. BRUNO, V., SCAPAGNINI, U. AND CANONICO, P. L.: Excitatory amino acids and neurotoxicity. Funct. Neurol. 8: 279-292, 1993.
7. BUCHKREMER-RATZMANN, I. AND WITTE, O. W.: Periinfarct and transhemispheric diaschisis caused by photothrombotic infarction in rat neocortex is reduced by lubeluzole but not MK-801. J. Cereb. Blood Flow Metab. 15: (Suppl. 1), S381, 1995.
8. CHOI, D. W., KOH, J-Y. AND PETERS, S.: Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J. Neurosci. 8: 185-196, 1988.
9. CHOI, D. W.: Methods for antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metabol. Rev. 2: 105-147, 1990.
10. DAWSON, V. L., DAWSON, T. M., LONDON, E. D., BREDT, D. S. AND SNYDER, S. H: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 88: 6368-6371, 1991.
11. DAWSON, V. L., DAWSON, T. M., BARTLEY, D. A., UHL, G. R. AND SNYDER, S. H: Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13: 2651-2661, 1993.
12. DE RYCK, M., KEERSMAEKERS, R., CLINCKE, G., JANSSEN, M. AND VAN REET, S.: Lubeluzole, a novel benzothiazole, protects neurologic function after cerebral thrombotic stroke in rats: An apparent stereospecific effect. Soc. Neurosci. Abstr. 20: 185, 1994.
13. DE RYCK, M., DE KEYSER, J., LESAGE, A., HANTSON, L. AND SWIJZEN, W.: Lubeluzole reduces mortality and improves functional outcome in the treatment of acute ischemic stroke: Early preclinical and clinical findings. In Ischemic Stroke. Recent Advances in Understanding Therapy, ed. by J. Grotta, L. P. Miller and A. M. Buchan, pp. 271-275, International Business Communications, Southborough, MA, 1995.
14. DIENER, H. C., HACKE, W., HENNERICI, M., DE KEYSER, J., RADBERG, J. AND HANTSON, L.: Lubeluzole in the acute treatment of ischemic stroke; results of a phase-2 trial. J. Cereb. Blood Flow Metab. 15: (Suppl. 1), S128, 1995.
15. FRANDSEN, A., ANDERSEN, C. F. AND SCHOUSBOE, A.: Possible role of cGMP in excitatory amino acid induced cytotoxicity in cultured cerebral cortical neurons. Neurochem. Res. 17: 35-43, 1992.
16. GARTHWAITE, J., CHARLES, S. L. AND CHESS-WILLIAMS, R.: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388, 1988.
17. GARTHWAITE, J., GARTHWAITE, G., PALMER, R. M. J. AND MONCADA S.: NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. Mol. Pharmacol. Section 172: 413-416, 1989.
18. GARTHWAITE, J.: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14: 60-67, 1991.
19. KLATT, P., SCHMIDT, K., URAY, G. AND MAYER, B.: Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of Nω-hydroxy-L-arginine as an intermediate. J. Biol. Chem. 268: 14781-14787, 1993.
20. KNOWLES, R. G., PALACIOS, M., PALMER, R. M. J. AND MONCADA, S.: Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 86: 5159-5162, 1989.
21. LAJTHA, A. AND SERSHEN, H.: Substrate specificity of uptake of diamines in mouse brain slice. Arch. Biochem. Biophys. 165: 539-547, 1974.
22. LESAGE, A. S., DE LOORE, K. L., PEETERS, L. AND LEYSEN, J. E.: Neuroprotective sigma ligands interfere with the glutamate-activated NOS pathway in hippocampal cell culture. Synapse 20: 156-164, 1995a.
23. LESAGE, A. S., DE LOORE, K. L., OSIKOWSKA-EVERS, B., PEETERS, L. AND LEYSEN, J. E.: Lubeluzole, a novel neuroprotectant, inhibits the glutamate-activated NOS pathway. J. Cereb. Blood Flow Metab. 15: (Suppl. 1), S432, 1995b.
24. LIPTON, S. A., CHOL, Y.-B., PAN, Z.-H., LEI, S. Z., CHEN, H. V., SUCHER, N. J., LOSCALZO, J., SINGEL, D. J. AND STAMLER, J. S.: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364: 626-632, 1993.
25. LOWENSTEIN, C. J., DINERMAN, J. L. AND SNYDER, S. H.: Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120: 227-237, 1994.
26. MANN, G. E., SHERIFF, C-J., TOOTHILL, J. J. AND PEARSON, J. D.: Application of rapid dual tracer dilution techniques for the study of endothelial cell amino transport in perfused microcarrier cultures. In Cell Membrane Transport: Experimental Approaches and Methodologies, ed. by D. L. Yudilevich, R. Devés, S. Peran and Z. I. Cabantchik, pp. 451-469, Plenum Press, New York, 1991.
27. MAYER, B., JOHN, M., HEINZEL, B., WERNER, R., WACHTER, H., SCHULTZ, G. AND BÖHME, E.: Brain nitric oxide synthase is a biopterin- and flavin- containing multi-functional oxido-reductase. FEBS Lett. 288: 187-191, 1991.
28. MCMILLAN, K., BREDT, D. S., HIRSCH, D. J., SNYDER, S. H., CLARK, J. E. AND MASTERS B. S. S.: Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc. Natl. Acad. Sci. U.S.A. 89: 11141-11145, 1992.
29. PAUWELS, P. J., LEYSEN, J. E. AND JANSSEN, P. A. J.: Resistance of sabeluzofe-treated rat brain neuronal cultures to neuronal damage. Neurosci. Res. Commun. 6: 19-26, 1990.
30. ROMIJN, H. J., VAN HUIZEN, F. AND WOLTERS, P. S.: Towards an improved serum-free, chemically defined medium for long-term culturing of cerebral cortex tissue. Neurosci. Behav. Rev. 8: 301-334, 1984.
31. SCHELLER, D., KOLB, J., SZATHMARY, S., ZACHARIAS, E., DE RYCK, M., VAN REEMPTS, J., CLINCKE, G. AND TEGTMEIER, F.: Extracellular changes of glutamate in the periinfarct zone. Effect of lubeluzole. J. Cereb. Blood Flow Metab. 15: (Suppl. 1), S379, 1995.
32. 2+/calmodulin-independent diaphorase and reductase activities. Biochemistry 31: 3243-3249, 1992.
33. SOUTHHAM, E. AND GARTHWAITE, J.: The nitric oxide - cyclic GMP signalling pathway in rat brain. Neuropharmacology 32: 1267-1277, 1993.
34. SOUTHAM, E., EAST, S. J. AND GARTHWAITE, J.: Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development. J. Neurochem. 56: 2072-2081, 1991.
35. ω-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266: 6259-6263, 1991.
36. STROLIN BENEDETTI, M., DOSTERT, P., MARRARI, P. AND CINI, M.: Effect of ageing on tissue levels of amino acids involved in the nitric oxide pathway in rat brain. J. Neural Transm. (GenSect) 94: 21-30, 1993.
37. 3H]arginine in cultured neurons: Characteristics and inhibition by nitric oxide synthase inhibitors. J. Neurochem. 61: 364-367, 1993.
38. ZHANG, J. AND SNYDER, S. H.: Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 89: 9382-9385, 1992.
39. ZHANG, J., DAWSON, V. L., DAWSON, T. M. AND SNYDER, S. H.: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689, 1994.